Actively Recruiting

Phase 2
Phase 3
Age: 18Years +
All Genders
NCT06697301

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Led by Eikon Therapeutics · Updated on 2026-05-08

740

Participants Needed

107

Research Sites

810 weeks

Total Duration

On this page

Sponsors

E

Eikon Therapeutics

Lead Sponsor

M

Merck Sharp & Dohme LLC

Collaborating Sponsor

AI-Summary

What this Trial Is About

The study is for patients with advanced melanoma who are eligible for standard therapy with Pembrolizumab.

CONDITIONS

Official Title

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma.

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Be 18 years of age or older at the time of informed consent.
  • Have a life expectancy of at least 3 months.
  • Have confirmed Stage 3 (unresectable) or Stage 4 metastatic melanoma.
  • Be eligible for standard therapy with pembrolizumab.
  • Have at least one measurable lesion by CT or MRI at baseline.
  • Have known BRAF V600 mutation status or agree to testing.
  • Completed prior radiotherapy at least 2 weeks before study treatment.
  • Have an ECOG Performance Status of 0 to 1.
  • Have adequate organ and marrow function based on recent lab tests.
  • Women of childbearing potential must have a negative pregnancy test within 72 hours before first dose.
  • Willing to use effective contraception or abstain from heterosexual activity during the study (applies to women of childbearing potential).
  • Male participants with partners who are women of childbearing potential must use approved contraception.
  • Able and willing to provide written informed consent.
Not Eligible

You will not qualify if you...

  • Melanoma of ocular origin.
  • Currently enrolled in or recently received investigational treatment with EIK1001 or placebo within 4 weeks or 5 half-lives.
  • Received prior systemic therapy for advanced melanoma (except permitted prior adjuvant or neoadjuvant therapies with conditions).
  • Experienced Grade 3 or higher adverse events from prior anti-PD-1 therapy.
  • Had major surgery less than 3 weeks before first dose.
  • Received live-virus vaccination within 30 days before first dose.
  • History of prior malignancy unless disease-free for 5 years after curative therapy.
  • Known active brain metastases or carcinomatous meningitis.
  • Mean resting QTcF over 470 ms on ECG.
  • Active autoimmune disease requiring systemic treatment in past 2 years, except certain conditions.
  • Chronic or recent systemic steroid or immunosuppressive treatment.
  • History or current pneumonitis or interstitial lung disease requiring steroids.
  • Active infections requiring treatment.
  • Uncontrolled HIV infection.
  • Positive hepatitis B or C virus test indicating active infection.
  • Conditions or treatments that could interfere with study participation.
  • Psychiatric or substance abuse disorders affecting cooperation.
  • History of regular illicit drug use or recent substance abuse including alcohol.
  • Pregnant, breastfeeding, or planning conception during the study.
  • Taking strong CYP3A4 or CYP1A2 inhibitors or inducers.

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 107 locations

1

Ironwood Cancer & Research Centers

Chandler, Arizona, United States, 85224

Actively Recruiting

2

Genesis Cancer and Blood Institute

Hot Springs, Arkansas, United States, 71913

Actively Recruiting

3

Helios Clinical Research

Los Angeles, California, United States, 90015

Actively Recruiting

4

Providence Medical Foundation

Santa Rosa, California, United States, 95403

Actively Recruiting

5

UCHealth Memorial Hospital Central

Colorado Springs, Colorado, United States, 80909

Actively Recruiting

6

Bioresearch Partner

Hialeah, Florida, United States, 33013

Actively Recruiting

7

The Center for Cancer and Blood Disorders

Bethesda, Maryland, United States, 20817

Actively Recruiting

8

MidAmerica Cancer Care

Kansas City, Missouri, United States, 64132

Actively Recruiting

9

Washington University School of Medicine in St. Louis

St Louis, Missouri, United States, 63108

Actively Recruiting

10

Gabrail Cancer Center Research LLC

Canton, Ohio, United States, 44718

Actively Recruiting

11

University of Pittsburgh Medical Center(UPMC)-Hillman Cancer Center

Pittsburgh, Pennsylvania, United States, 15232

Actively Recruiting

12

Cancer Care Wollongong

Wollongong, New South Wales, Australia, 2500

Actively Recruiting

13

Icon Cancer Centre Chermside

Chermside, Queensland, Australia, 4032

Actively Recruiting

14

Southern Adelaide Local Health Network Incorporated Flinders Medical Centre

Bedford Park, South Australia, Australia, 5042

Actively Recruiting

15

Eastern Health

Box Hill, Victoria, Australia, 3128

Actively Recruiting

16

Peninsula and South Eastern Haematology and Oncology Group

Frankston, Victoria, Australia, 3199

Actively Recruiting

17

Universitätsklinikum Graz

Graz, Styria, Austria, 8036

Actively Recruiting

18

Universitair Ziekenhuis Antwerpen

Edegem, Antwerpen, Belgium, 2650

Actively Recruiting

19

Cliniques Universitaires Saint-Luc

Brussels, Brussels Capital, Belgium, 1200

Actively Recruiting

20

Centre Hospitalier Universitaire Universite Catholique de Louvain - Site Godinne

Yvoir, Namur, Belgium, B-5530

Actively Recruiting

21

Universitair Ziekenhuis Leuven - Campus Gasthuisberg

Leuven, Vlaams Brabant, Belgium, 3000

Actively Recruiting

22

Algemeen Ziekenhuis Groeninge - Campus Kennedylaan

Kortrijk, West-Vlaanderen, Belgium, 8500

Actively Recruiting

23

Vitaz Primary Location

Sint-Niklaas, Belgium, 9100

Actively Recruiting

24

Sunnybrook Research Ins<tute

Toronto, Ontario, Canada, M4N 3M5

Actively Recruiting

25

Masaryk Memorial Cancer Institute

Brno, Brno, Czechia, 65653

Actively Recruiting

26

University Hospital Hradec Kralove

Sokolov, Hradce Kralove, Czechia, 50009

Actively Recruiting

27

Aarhus Universitetshospital

Aarhus, Central Jutland, Denmark, 8200

Actively Recruiting

28

Aalborg University Hospital

Aalborg, Nord Jutland, Denmark, 9000

Actively Recruiting

29

Oulu University Hospital

Oulu, Oulu, Finland, 90230

Actively Recruiting

30

Tampere University Hospital

Tampere, Pirkanmaa, Finland, 33521

Actively Recruiting

31

Helsinki University Hospital

Helsinki, Uusimaa, Finland, 00029

Actively Recruiting

32

Centre Hospitalier Lyon-Sud

Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495

Actively Recruiting

33

A Paré

Boulogne, Boulogne, France, 92104

Actively Recruiting

34

Centre Hospitalier Universitaire Grenoble Alpes

La Tronche, Isère, France, 38700

Actively Recruiting

35

CHU Lille

Polonovski, Lille Cedex, France, 59037

Actively Recruiting

36

Hôpital La Timone

Marseille, Marseille, France, 13385

Actively Recruiting

37

Centre Hospitalier Universitaire (CHU) Nice

Nice, PACA, France, 06200

Actively Recruiting

38

Hôpital Bichat AP-HP Université Paris Cité

Paris, Paris, France, 75018

Actively Recruiting

39

ICO Saint Herblain

Saint-Herblain, Pays de la Loire Region, France, 44800

Actively Recruiting

40

CHU Rouen

Rouen, Rouen, France, 76031

Actively Recruiting

41

Hospital Saint Andre

Bordeaux, France, 33075

Actively Recruiting

42

Universitätsmedizin Mannheim

Mannheim, Baden-Wurttemberg, Germany, 68167

Actively Recruiting

43

Universitaetsklinikum Tuebingen (UKT)

Tübingen, Baden-Wurttemberg, Germany, 72076

Actively Recruiting

44

Klinik für Dermatologie, Venerologie und Allergologie

Würzburg, Bavaria, Germany, 97080

Actively Recruiting

45

Universitätsklinik Hamburg Eppendorf

Martinsried, Free and Hanseatic City of Hamburg, Germany, 20246

Actively Recruiting

46

Universitat Leipzig

Saxony, Leipzig, Germany, 04103

Actively Recruiting

47

Elbe Kliniken Stade-Buxtehude

Buxtehude, Lower Saxony, Germany, 21614

Actively Recruiting

48

Johannes Wesling Klinikum Minden

Minden, North Rhine-Westphalia, Germany, 32429

Actively Recruiting

49

University of Mainz Medical Center

Mainz, RLP, Germany, 55131

Actively Recruiting

50

Universitätsklinikum Schleswig-Holstein - Campus Kiel

Kiel, Schleswig-Holstein, Germany, 24105

Actively Recruiting

51

Universitätsklinikum Schleswig-Holstein - Campus Lübeck

Lübeck, Schleswig-Holstein, Germany, 23538

Actively Recruiting

52

Charite Department of Dermatology, Venereology and Allergology

Berlin, State of Berlin, Germany, 10115

Actively Recruiting

53

Fachklinik Hornheide

Münster, Germany, 48157

Actively Recruiting

54

National Institute of Oncology

Budapest, Budapest, Hungary, 1122

Actively Recruiting

55

University of Pécs

Pécs, Hungary, 7632

Actively Recruiting

56

Soroka medical center

Beersheba, Be'er Sheva, Israel, 8410101

Actively Recruiting

57

Rabin Medical Center

Petah Tikva, Petach Tikva, Israel, 4941492

Actively Recruiting

58

Ella Lemelbaum Institute for Immuno-Oncology and Melanoma

Ramat Gan, Ramat Gan, Israel, 5262100

Actively Recruiting

59

Tel Aviv Medical Center

Tel Aviv, Tel Aviv, Israel, 6423906

Actively Recruiting

60

IRCCS Ospedale San Raffaele

Milan, Milano, Italy, 20132

Actively Recruiting

61

Humanitas Gavazzeni Bergamo

Bergamo, Province of Bergamo, Italy, 24125

Actively Recruiting

62

Clinica Oncologia Delle Marche

Ancona, The Marches, Italy, 60126

Actively Recruiting

63

UOC Immunoterapia Oncologica

Siena, Tuscany, Italy, 53100

Actively Recruiting

64

Christchurch Public Hospital

Christchurch, Christchurch, New Zealand, 8011

Actively Recruiting

65

Auckland City Hospital

Auckland, New Zealand, New Zealand, 1023

Actively Recruiting

66

Nordland Hospital Trust

Bodø, Bodø, Norway, N-8005

Actively Recruiting

67

Oslo University Hospital - The Norwegian Radium Hospital

Oslo, Oslo, Norway, 0310

Actively Recruiting

68

Drammen Hospital

Drammen, Oslofjord, Norway, 3004

Actively Recruiting

69

Uniwersyteckie Centrum Kliniczne

Gdansk, Gdańsk, Poland, 80-952

Actively Recruiting

70

Prezychodnia Lekarska KOMED Roman Karaszewski

Konin, Konin, Poland, 62-500

Actively Recruiting

71

Mazowiecki Szpital Wojewódzki, Siedlckie Centrum Onkologii

Siedlce, Siedlce, Poland, 08-110

Actively Recruiting

72

Maria Sklodowska-Curie National Cancer Research Institute

Warsaw, Warsaw, Poland, 02-781

Actively Recruiting

73

IPO Lisboa

Lisbon, Lisbon District, Portugal, 1099-023

Actively Recruiting

74

Hospital da Luz Lisboa

Lisbon, Lisbon District, Portugal, 1500-650

Actively Recruiting

75

Military Medical Academy- Department of Oncology

Belgrade, Belgrade, Serbia, 11000

Actively Recruiting

76

Cancercare Port Elizabeth - Langenhoven Drive Oncology Centre

Port Elizabeth, Eastern Cape, South Africa, 6045

Actively Recruiting

77

University of Pretoria, Steve Biko Academic Hospital

Pretoria, Gauteng, South Africa, 0002

Actively Recruiting

78

The Medical Oncology Centre of Rosebank

Saxonwold, Gauteng, South Africa, 2196

Actively Recruiting

79

Abraham Oncology

Richards Bay, KwaZulu-Natal, South Africa, 3900

Actively Recruiting

80

Curo Oncology

Pretoria, Pretoria, South Africa, 0084

Actively Recruiting

81

Cape Town Oncology Trials

Cape Town, Western Cape, South Africa, 7570

Actively Recruiting

82

TASK Eden

George Central, Western Cape, South Africa, 6530

Actively Recruiting

83

Kyungpook National University Chilgok Hospital

Buk-Gu, Daegu, South Korea, 41404

Actively Recruiting

84

Seoul National University Hospital

Jongno-gu, Seoul, South Korea, 03080

Actively Recruiting

85

H. Germans Trias I Pujol (ICO-Badalona)

Badalona, Badalona, Spain, 08916

Actively Recruiting

86

Hospital Universitari Dexeus

Barcelona, Barcelona, Spain, 08028

Actively Recruiting

87

Vall d' Hebron Institute of Oncology

Barcelona, Barcelona, Spain, 08035

Actively Recruiting

88

San Pedro de Alcántara Hospital

Cáceres, Cáceres, Spain, 10003

Actively Recruiting

89

Hospital Universitario Lucus Augusti

Lugo, Galicia, Spain, 27003

Actively Recruiting

90

Institut Català d'Oncologia Girona (ICO Girona)

Girona, Girona, Spain, 17007

Actively Recruiting

91

University Hospital of Jerez

Jerez de La Frontera (Cádiz), Jerez de La Frontera (Cádiz), Spain, 11407

Actively Recruiting

92

GenesisCare Madrid - Hospital San Francisco de Asís

Madrid, Madrid, Spain, 28002

Actively Recruiting

93

Hospital General Universitario Gregorio Marañón

Madrid, Madrid, Spain, 28007

Actively Recruiting

94

HM CIOCC

Madrid, Madrid, Spain, 28050

Actively Recruiting

95

Hospital 12 de Octubre

Usera, Madrid, Spain, 28031

Actively Recruiting

96

Hospital Regional Universitario

Málaga, Malaga, Spain, 29011

Actively Recruiting

97

Hospital Universitario Virgen de la Victoria

Málaga, Málaga, Spain, 29010

Actively Recruiting

98

IVO - Fundacion Instituto Valenciano de Oncologia

Valencia, Valencia, Spain, 46009

Actively Recruiting

99

INCLIVA Instituto de Investigación Sanitaria

Valencia, Valencia, Spain, 46010

Actively Recruiting

100

Gävle Sjukhus

Gävle, Gävleborg County, Sweden, 801 88

Actively Recruiting

101

Karolinska University Hospital

Stockholm, Södermanland County, Sweden, 17176

Actively Recruiting

102

Universitätsspital Zürich

Zurich, Canton of Zurich, Switzerland, 8091

Actively Recruiting

103

Kantonsspital Graubünden

Chur, Chur, Switzerland, 7000

Actively Recruiting

104

Belfast City Hospital, Belfast Health and Social Care Trust

Belfast, Belfast, United Kingdom, BT9 7AB

Actively Recruiting

105

Guy's and St Thomas' NHS Foundation Trust

London, England, United Kingdom, SE1 9RT

Actively Recruiting

106

Sarah Cannon Research Institute London

London, England, United Kingdom, W1G6AD

Actively Recruiting

107

University Hospital Southampton

Southampton, Hampshire, United Kingdom, SO32 2DA

Actively Recruiting

Loading map...

Research Team

K

Krishna Kaza

CONTACT

J

Juliette Beaulieu

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

QUADRUPLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Safety and Efficacy of EIK1001 in Combo With Pembro Versus Placebo and Pembro as First-Line Therapy in Patients With Advanced Melanoma. | DecenTrialz